Brainstorm Cell Therapeutics shares owned by HighTower Advisors
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by HighTower Advisors
from 13F filings
Historical chart of HighTower Advisors investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Brainstorm Cell Therapeutics by HighTower Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.0k | 10k | 0.29 |
2023-09-30 | $2.0k | 11k | 0.19 |
2021-03-31 | $40k | 11k | 3.80 |
2019-09-30 | $40k | 10k | 3.90 |
2019-06-30 | $41k | 10k | 3.99 |
2019-03-31 | $46k | 11k | 4.27 |
2018-12-31 | $39k | 11k | 3.62 |
2018-09-30 | $41k | 11k | 3.81 |
2018-06-30 | $42k | 11k | 3.90 |
2018-03-31 | $35k | 11k | 3.25 |
2017-12-31 | $42k | 11k | 3.90 |
2017-09-30 | $42k | 10k | 4.09 |
2017-06-30 | $43k | 10k | 4.19 |
2017-03-31 | $46k | 11k | 4.27 |
2016-12-31 | $27k | 11k | 2.51 |
2016-09-30 | $26k | 11k | 2.42 |
2016-06-30 | $26k | 11k | 2.42 |
2016-03-31 | $29k | 11k | 2.69 |
2015-03-31 | $54k | 12k | 4.40 |
2014-12-31 | $49k | 10k | 4.77 |